Persistent hypogammaglobulinemia after rituximab therapy in pediatric patients, prevalence and clinical outcomes
{{output}}
Hypogammaglobulinemia is a known side effect of rituximab (RTX) in adults, but its prevalence and persistence in children remain underexplored. This retrospective cohort study at a tertiary care center examines the prevalence and clinical outcomes of hypogamma... ...
